BCWM
CINC

Bartlett & Co Wealth Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Bartlett & Co Wealth Management’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-800
Closed -$9.83K – 1115
2022
Q4 		$9.83K Hold
800
– – ﹤0.01% 831
2022
Q3 		$26.3K Buy
+800
New +$22.6K ﹤0.01% 662

Bartlett & Co Wealth Management's CINC Position: Q1 2023 in Review

Bartlett & Co Wealth Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 800 shares — an estimated $9.83K sold.

Bartlett & Co Wealth Management first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $26.3K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Bartlett & Co Wealth Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 800 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $9.83K.
  • Bartlett & Co Wealth Management first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Bartlett & Co Wealth Management's CinCor Pharma, Inc. Common Stock position peaked at $26.3K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2023, filed 14 Feb 2024.